NO162817C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-aryl-4-piperidin-carbinoler. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-aryl-4-piperidin-carbinoler.Info
- Publication number
- NO162817C NO162817C NO831588A NO831588A NO162817C NO 162817 C NO162817 C NO 162817C NO 831588 A NO831588 A NO 831588A NO 831588 A NO831588 A NO 831588A NO 162817 C NO162817 C NO 162817C
- Authority
- NO
- Norway
- Prior art keywords
- aryl
- preparation
- therapeutic effective
- piperidine carbinols
- analogue procedure
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37622982A | 1982-05-07 | 1982-05-07 | |
| US06/468,040 US4485109A (en) | 1982-05-07 | 1983-02-25 | 4-Aryl-4-piperidinecarbinols |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO831588L NO831588L (no) | 1983-11-08 |
| NO162817B NO162817B (no) | 1989-11-13 |
| NO162817C true NO162817C (no) | 1990-02-21 |
Family
ID=27007350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO831588A NO162817C (no) | 1982-05-07 | 1983-05-05 | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-aryl-4-piperidin-carbinoler. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4485109A (no) |
| EP (1) | EP0094018B1 (no) |
| AU (1) | AU560166B2 (no) |
| CA (1) | CA1252790A (no) |
| DE (1) | DE3375915D1 (no) |
| DK (1) | DK161699C (no) |
| ES (1) | ES8501750A1 (no) |
| FI (1) | FI78685C (no) |
| GR (1) | GR77502B (no) |
| HU (1) | HU188278B (no) |
| IE (1) | IE55994B1 (no) |
| IL (1) | IL68586A0 (no) |
| NO (1) | NO162817C (no) |
| NZ (1) | NZ204150A (no) |
| PH (1) | PH18380A (no) |
| PT (1) | PT76657B (no) |
| SU (1) | SU1187718A3 (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5019650A (en) * | 1988-03-28 | 1991-05-28 | E. I. Du Pont De Nemours And Company | 4-aryl-4-piperidine (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof |
| US5086063A (en) * | 1988-03-28 | 1992-02-04 | Du Pont Merck Pharmaceutical Company | 4-aryl-4-piperidine (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof |
| CA1337418C (en) * | 1988-03-28 | 1995-10-24 | Engelbert Ciganek | 4-aryl-4-piperiding (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof |
| FR2639226B1 (fr) * | 1988-11-18 | 1993-11-05 | Sanofi | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs |
| EP0412798A3 (en) * | 1989-08-08 | 1992-07-01 | Merck Sharp & Dohme Ltd. | Substituted pyridines, their preparation, formulations and use in dementia |
| USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
| WO2002046156A2 (en) * | 2000-12-06 | 2002-06-13 | Sepracor, Inc. | 4,4-disubstituted piperidines for use as dopamine, serotonin and norepinephrine ligands |
| EP1441718B1 (en) * | 2001-10-16 | 2006-07-12 | Endo Pharmaceuticals Inc. | Use of carbinols for the treatment of neuropathic dysfunction |
| WO2004039778A1 (en) * | 2002-11-01 | 2004-05-13 | Neurosearch A/S | Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| SE0401465D0 (sv) * | 2004-06-08 | 2004-06-08 | Carlsson A Research Ab | New substituted piperdines as modulators of dopamine neurotransmission |
| HUE029790T2 (hu) * | 2004-10-13 | 2017-04-28 | Teva Pharmaceuticals Int Gmbh | Eljárás 4-(3-metánszulfonil-fenil)-l-N-propil-piperidin elõállítására |
| CN101068782A (zh) * | 2004-10-13 | 2007-11-07 | 神经研究瑞典公司 | 合成4－(3－磺酰基苯基)－哌啶类的方法 |
| UY34503A (es) | 2011-12-08 | 2013-07-31 | Ivax Int Gmbh | ?sal de bromhidrato de pridopidina? |
| AU2013243461A1 (en) | 2012-04-04 | 2014-11-06 | Teva Pharmaceuticals International Gmbh | Pharmaceutical compositions for combination therapy |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL88235C (no) * | 1950-12-05 | |||
| FR1049588A (fr) * | 1950-12-05 | 1953-12-30 | Schering Corp | Procédé ?? préparation de pipéridines substituées |
| US2832786A (en) * | 1956-02-27 | 1958-04-29 | Wm S Merrell Co | Phosphoramides |
| AT214445B (de) * | 1957-08-14 | 1961-04-10 | Thomae Gmbh Dr K | Verfahren zur Herstellung von neuen, substituierten 1-(β-Oxyäthyl)-4-phenylpiperidinen |
| GB841120A (en) * | 1958-02-12 | 1960-07-13 | J F Macfarlan & Co Ltd | Improvements in or relating to piperidine compounds |
| GB888657A (en) * | 1958-07-14 | 1962-01-31 | J F Macfarlan & Co Ltd | Piperidine carbinols |
| US3080372A (en) * | 1960-03-25 | 1963-03-05 | Res Lab Dr C Janssen | 1-aroylalkyl-4-arylpiperidine derivatives |
| US3108211A (en) * | 1960-08-08 | 1963-10-22 | Electro Sonic Ind Inc | Activation of ferroelectric elements |
| GB1243991A (en) * | 1968-06-10 | 1971-08-25 | Ici Ltd | Piperidine, morpholine and piperazine derivatives |
| US3824242A (en) * | 1973-01-26 | 1974-07-16 | Research Corp | Synthesis of meperidine |
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| US3998832A (en) * | 1975-04-16 | 1976-12-21 | G. D. Searle & Co. | Anti-diarrheal compounds |
| AU509558B2 (en) * | 1976-10-18 | 1980-05-15 | G. D. Seale & Co | 1-(3, 3, 3-triarylalkyl1) 4-phenyl-piperidinemethanol ethers |
| US4241071A (en) * | 1977-01-27 | 1980-12-23 | American Hoechst Corporation | Antidepressant (α-phenyl-2-tolyl)azacycloalkanes |
| FR2408602A2 (fr) * | 1977-11-15 | 1979-06-08 | Synthelabo | Nouveaux derives de piperidine et leur methode de preparation |
| US4228288A (en) * | 1978-11-29 | 1980-10-14 | Eli Lilly And Company | Certain substituted 3,4,5,6-tetrahydropyridinium salt intermediates |
| US4284635A (en) * | 1978-11-29 | 1981-08-18 | Eli Lilly And Company | Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines |
| US4277608A (en) * | 1979-06-21 | 1981-07-07 | Eli Lilly And Company | Method of preparing 4a-arylhexahydro-1H-2-pyrindines and 4a-aryloctahydroisoquinolines |
| US4236009A (en) * | 1979-06-21 | 1980-11-25 | Eli Lilly And Company | Method of preparing 4A-arylhexahydro-1H-2-pyrindines and 4A-aryloctahydroisoquinolines |
-
1983
- 1983-02-25 US US06/468,040 patent/US4485109A/en not_active Expired - Lifetime
- 1983-05-04 GR GR71306A patent/GR77502B/el unknown
- 1983-05-04 DE DE8383104366T patent/DE3375915D1/de not_active Expired
- 1983-05-04 EP EP83104366A patent/EP0094018B1/en not_active Expired
- 1983-05-05 CA CA000427534A patent/CA1252790A/en not_active Expired
- 1983-05-05 PH PH28859A patent/PH18380A/en unknown
- 1983-05-05 IL IL68586A patent/IL68586A0/xx not_active IP Right Cessation
- 1983-05-05 NO NO831588A patent/NO162817C/no unknown
- 1983-05-05 ES ES522120A patent/ES8501750A1/es not_active Expired
- 1983-05-06 DK DK205083A patent/DK161699C/da not_active IP Right Cessation
- 1983-05-06 FI FI831567A patent/FI78685C/fi not_active IP Right Cessation
- 1983-05-06 PT PT76657A patent/PT76657B/pt not_active IP Right Cessation
- 1983-05-06 HU HU831582A patent/HU188278B/hu not_active IP Right Cessation
- 1983-05-06 SU SU833588607A patent/SU1187718A3/ru active
- 1983-05-06 AU AU14311/83A patent/AU560166B2/en not_active Ceased
- 1983-05-06 IE IE1040/83A patent/IE55994B1/en not_active IP Right Cessation
- 1983-05-06 NZ NZ204150A patent/NZ204150A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES522120A0 (es) | 1984-12-01 |
| HU188278B (en) | 1986-03-28 |
| NO162817B (no) | 1989-11-13 |
| CA1252790A (en) | 1989-04-18 |
| FI78685B (fi) | 1989-05-31 |
| IL68586A0 (en) | 1983-09-30 |
| IE831040L (en) | 1983-11-07 |
| DK205083D0 (da) | 1983-05-06 |
| DK161699C (da) | 1992-01-13 |
| GR77502B (no) | 1984-09-24 |
| IE55994B1 (en) | 1991-03-13 |
| PT76657A (en) | 1983-06-01 |
| PH18380A (en) | 1985-06-19 |
| EP0094018A2 (en) | 1983-11-16 |
| DE3375915D1 (de) | 1988-04-14 |
| SU1187718A3 (ru) | 1985-10-23 |
| ES8501750A1 (es) | 1984-12-01 |
| AU1431183A (en) | 1983-11-10 |
| EP0094018B1 (en) | 1988-03-09 |
| AU560166B2 (en) | 1987-04-02 |
| FI831567A0 (fi) | 1983-05-06 |
| FI78685C (fi) | 1989-09-11 |
| EP0094018A3 (en) | 1985-11-06 |
| DK205083A (da) | 1983-11-08 |
| NZ204150A (en) | 1985-05-31 |
| PT76657B (en) | 1986-04-16 |
| FI831567L (fi) | 1983-11-08 |
| US4485109A (en) | 1984-11-27 |
| DK161699B (da) | 1991-08-05 |
| NO831588L (no) | 1983-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO821198L (no) | Fremgangsmaate for fremstilling av preparater for behandling av melanomer. | |
| NO156785C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater. | |
| NO833705L (no) | Fremgangsmaate for fremstilling av fenyl-piperidin-propanol-forbindelser. | |
| NO161002C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider. | |
| NO150760C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler. | |
| NO163285C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive steroider. | |
| NO165027C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive propenyl-cefalosporinforbindelser. | |
| NO159667C (no) | Fremgangsmaate for fremstilling av kikhostetoksid. | |
| NO157861C (no) | Analogifremgangsmaate til fremstilling av aminopyridaziner. | |
| NO154492C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser. | |
| NO161317C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer. | |
| NO814065L (no) | Fremgansmaate for fremstilling av imidazolylfenylamidiner | |
| NO162817C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-aryl-4-piperidin-carbinoler. | |
| NO158460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| NO157976C (no) | Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider. | |
| NO812519L (no) | Fremgangsmaate for fremstilling av kolesterase. | |
| NO157735C (no) | Fremgangsmaate for fremstilling av alfa-arylalkansyrer. | |
| NO159090C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater. | |
| NO163570C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner. | |
| NO156167C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater. | |
| NO158800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater. | |
| NO162018C (no) | Fremgangsmaate for fremstilling av 4-metyl-5-alkyltiometylimidazoler. | |
| NO162188C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner. | |
| NO160203C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme fenotiazin-forbindelser. | |
| NO155842C (no) | Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider. |